Abstract:Abstract Objective: To investigate the value of carcinoembryonic antigen (CEA) change in predicting pathological tumor regression and outcome for locally advanced rectal cancer (LARC) patients received neoadjuvant therapy. Material and methods: LARC patients who received neoadjuvant therapy and radical tumor resection were retrospectively collected. The predictive value of baseline CEA, post-treatment CEA and post/pre-treatment CEA ratio for tumor regression grade (TRG), overall survival and diseases free survival were estimated by logistic regression or cox proportional hazard regression. Results: 700 LARC patients were enrolled in the study with 475 (67.9%) cases of male patients and median age of 56 (20-87). Of the all patients enrolled, multivariate analysis showed post-treatment CEA (OR=1.142, 95% CI: 1.073-1.215, P<0.001) was an independent predictor for TRG. 284 patients with elevated baseline CEA were analyzed. Among them, 168 patients (59.2%) have normalized CEA. Multivariate analysis showed post-treatment CEA (OR=1.068, 95% CI: 1.007-1.133, P=0.027), CEA ratio (OR=3.463, 95% CI: 1.269-9.446, P=0.015) were independent predictors for TRG(Table 1). Of the all patients enrolled, multivariate analysis showed low preoperative albumin level (HR=0.919, 95% CI: 0.886-0.952, P<0.001), tumor deposit (HR=3.226, 95% CI: 1.470-7.077, P=0.003), nerve infiltration (HR=3.602, 95% CI: 1.736-7.476, P=0.001), high post-treatment CEA (HR=1.029, 95% CI: 1.010-1.049, P=0.003) were independent unfavored predictors for overall survival of LARC patients. 700 patients were divided into 3 groups: A group with normal baseline CEA (n=416,59.4%); B group with normalized CEA (n=168,24.0%); C group with elevated baseline and post-treatment CEA (n=116,16.6%). The overall survival and disease free survival of group B were comparable to that of group A (P=0.588,0.053) and significantly better than that of group C (B vs. C: P=0.010, 0.003; A vs. C: P=0.007, <0.001). Conclusion: 1. Post-treatment CEA is an independent predictor for TRG of LARC patients and higher post-treatment CEA precdicted poor overall survival. 2. Post/pre-treatment CEA ratio is an independent predictor for TRG of LARC patients with elevated baseline CEA. Citation Format: Zerong Cai, Lingyu Huang, Ping Lan, Xiaojian Wu. Serum CEA change predicts tumor regression and prognosis in locally advanced rectal cancer [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3197.

Relationship among CEA, CA199, clinical pathological characteristics and prognosis in patients with rectal cancer

Prognostic value of preoperative CA199 in advanced colorectal cancer patients with normal carcinoembryonic antigen level

[Predictive Value of Preoperative Detection of CEA and CA199 for Prognosis in Patients with Stage II-III Colorectal Cancer].

Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy

The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients

Clinical Significance of Serum CEA and Serum CA199 in Patients with Colonic and Rectal Cancer Postoperatively

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA.

The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I ~ III Colorectal Cancer

Cmar_a_246566 2767..2775

Postoperative Carcinoembryonic Antigen (CEA) Levels Predict Outcomes after Resection of Colorectal Cancer in Patients with Normal Preoperative CEA Levels.

Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative.

Abstract 3197: Serum CEA Change Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer

Combination of Carcinoembryonic Antigen with the American Joint Committee on Cancer TNM Staging System in Rectal Cancer: a Real-World and Large Population-Based Study

Effect of elevated CEA levels on the outcome of colorectal cancer patients with different histopathologic types: A SEER population-based study

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study

[Predictive Value of Serum Carcinoembryonic Antigen Level in Efficacy and Prognosis for Patients with Rectal Cancer Following Preoperative Radiochemotherapy].

Combined Detection of Preoperative Serum CEA, CA19-9 and CA242 Improve Prognostic Prediction of Surgically Treated Colorectal Cancer Patients.

The Role of Half-life of Carcinoembryonic Antigen (CEA) in Prognosis Prediction of Colorectal Cancer Patients with Preoperatively Elevated CEA

High Expression Of Serum Carcinoembryonic Antigen (Cea) Associated With Poor Prognosis In Early Gastric Cancer: A Single-Center Retrospective Study

Preoperative Serum Carcinoembryonic Antigen, Carbohydrate Antigen19-9 and Carbohydrate Antigen 125 as Prognostic Factors for Recurrence-free Survival in Colorectal Cancer

Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer